BETABiohacksAI is a research tool for informational purposes only. All outputs are computational hypothesis candidates — not confirmed mechanisms, not medical advice, and not a substitute for professional medical judgment. Independent experimental validation is always required.
BiohacksAI is an evolving scientific literature platform. New compounds and evidence are indexed continuously.
B
○

Cefuroxime

Cefuroxime Broad-spectrum cephalosporin antibiotic resistant to beta-lactamase. It has been proposed for infections with gram-negative and gram-positive organisms, GONORRHEA, and HAEMOPHILUS.

299+ PubMed studies analyzed · 79 RCTs · Evidence Score: 54.6

Research Domains

Cefuroxime has been studied across 11 research domains including 👁️ Vision & Eye, 🫁 Respiratory, 🧠 Focus & Attention, 😴 Sleep, 🫘 Kidney. The primary research focus is 👁️ Vision & Eye with 11% of studies addressing this area.

Similar Compounds by Shared Targets

The following compounds share molecular targets with Cefuroxime, based on binding affinity data from BindingDB and ChEMBL. Sorted by shared target overlap.

Cefamandole
5 shared targets
Cefmetazole
3 shared targets
Cefoxitin
4 shared targets
Cephradine
3 shared targets
Abacavir
3 shared targets
etravirine
2 shared targets
Cefoperazone
3 shared targets
Ceftriaxone
4 shared targets
Diflucortolone
2 shared targets
Emtricitabine
2 shared targets
Loading evidence profile...

This evidence profile for Cefuroxime is generated deterministically from 299 PubMed-indexed studies. All data is corpus-verified with Merkle proofs. BiohacksAI does not provide medical advice. Always consult a healthcare professional before starting any supplement regimen.

Data source: PubMed/MEDLINE (NLM). Corpus version: current. Patent pending (EVE-PAT-2026-001). © 2026 Organiq Sweden AB.